Prediction of Bitter Taste Receptor’s Active Site | Chapter 06 | Modern Advances in Pharmaceutical Research Vol. 3
Non-steroidal anti-inflammatory drugs
(NSAIDs) are considered as the best treatment for conditions associated with
pain, fever and inflammation. Non-steroidal anti-inflammatory drugs exert their
therapeutic effects by blocking prostaglandin synthesis from arachidonic acid,
which inhibits the activity of cyclooxygenases (COX-1 and COX-2). COX-1 is
located in the stomach, kidney and other tissues, while COX-2 is located at
inflammation sites. One of the disadvantages of the NSAIDs is their bitter
sensation. This chapter discusses a novel approach to be used in the design of
active sites of bitter taste receptors, especially TAS2R14, by using the X-ray
crystal structure of the enzyme COX-2 and chemical structures of commonly used
non-steroidal anti-inflammatory drugs (NSAIDs) that bind effectively to COX
enzymes and activate the bitter taste receptor TAS2R14. The suggested approach
consists of docking calculations of the NSAIDs (ligands) to the active site of
COX-2 and utilizing the data obtained in better understanding the nature of the
interactions between bitter tastants and the chemical groups within the active
site of TAS2R14 receptor.
Author(s) Details
Rafik Karaman
Department of Pharmaceutical
Sciences, Faculty of Pharmacy, Al-Quds
University, Jerusalem, Palestine.
Salma Jumaa
Department of Pharmaceutical
Sciences, Faculty of Pharmacy, Al-Quds
University, Jerusalem, Palestine.
Gennaro Mecca
Exo Research Organization,
Potenza, Italy.
Comments
Post a Comment